Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Coherus BioSciences, Inc. (NASDAQ:CHRS), a commercial-stage biopharmaceutical company with a market capitalization of approximately $149 million, has undergone a significant transformation in recent ...

MidAmerica Cancer Care (MACC) has announced its partnership with American Oncology Network (AON), a community-based oncology ...

David M. Waterhouse, MD, MPH, and Molly Mendenhall, MBOE, LSSBB, BSN, RN, discuss how the implementation of Lean Six Sigma methodology at Oncology Hematology Care in Cincinnati, Ohio, has transformed ...

The Federal Government of Nigeria has launched a leadership programme for women in oncology, aimed at promoting inclusiveness ...

In Part 5 of our Life Sciences Industry Report, we turn our attention to the oncological field of research and development, from cancer therapies to cancer care, from clinical trials to the patient’s ...

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

Lucknow: KGMU has launched a dedicated gynae oncology department that will provide specialised care under one roof, as gynaecological related cancers .

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.

Some six and a half years since its debut, Servier’s U.S. arm has made good on its oncology growth ambitions while managing to stay true to its patient-centric ethos along the way. | Some six and a ...

Researchers identified the enzyme CMPK2 as a possible target for therapies aiming to prevent metabolic dysfunction-associated ...